Activity of ceftazidime (GR 20263) against nosocomially important pathogens
- PMID: 7023381
- PMCID: PMC181609
- DOI: 10.1128/AAC.19.6.1067
Activity of ceftazidime (GR 20263) against nosocomially important pathogens
Abstract
Ceftazidime was considerably more active than cefuroxime against 180 strains of resistant species of nosocomial gram-negative bacteria. In terms of antibacterial spectrum and intrinsic activity, ceftazidime is an improvement upon existing beta-lactam antibiotics in clinical use and can be regarded as a possible alternative to gentamicin.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
